XM does not provide services to residents of the United States of America.

At least four companies launch Hong Kong IPOs to raise about $500 million



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-At least four companies launch Hong Kong IPOs to raise about $500 million</title></head><body>

Adds Cirrus Aircraft ownership details in fourth paragraph

By Scott Murdoch

SYDNEY, June 28 (Reuters) - At least fourcompanies ranging from a U.S.-based jet manufacturer to a Chinese generative AI firm launched Hong Kong initial public offerings on Friday to raise up to $500 million, according to their regulatory filings.

Cirrus Aircraft, a Minnesota-based small jet manufacturer, is aiming to raise up to $197 million by selling 54.87 million shares in a price range of HK$27.34 to HK$28 per share.

An IPO priced at the top of thatrange wouldvalue Cirrus at $1.3 billion and cornerstone investors have subscribed for about $109 million worth of shares available in the deal.

Cirrus was acquired by state-owned China Aviation Industry General Aircraft (CAIGA) in 2011. It will control about 85% of the company once the IPO is complete, according to Cirrus's listing documents.

Riding hailing app Chenqi Technology is selling 30 million shares in a range of HK$34 to HK$45.40 per share to raise up to $174 million.

AI firm Shanghai Voicecomm is looking to raise $85 million be selling 4.36 million shares at a fixed price of HK$152.10 per share.

Baiwang, a financial data analytical firm backed by Alibaba, is selling 9.62 million shares in a range of $HK36 to HK$40 each to raise up to nearly $50 million.

Three smaller companies GL-Carlink Technology, Ruichang International and Fangzhou are looking to raise a combined $50 million, regulatory filings show.

The rush of IPOs comes as the value of new share sales in Hong Kong fell from $2.12 billion in the first half of 2023 to $1.46 billion in the 2024 first half, LSEG data showed.

Despite the weak performance in Hong Kong, bankers are hoping an increase in Chinese regulatory approvals and a surge in Indian deals will make Asia an equity capital market hotspot in the second half of 2024.



Reporting by Scott Murdoch; Editing by Michael Perry and Kim Coghill

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.